Role of macrophage evolution in hepatic adaptation to alcohol.
巨噬细胞进化在肝脏适应酒精中的作用。
基本信息
- 批准号:10515320
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-10-01 至 2023-09-30
- 项目状态:已结题
- 来源:
- 关键词:Acute Alcoholic HepatitisAffectAlcoholic HepatitisAlcoholic Liver CirrhosisAlcoholic Liver DiseasesAlcoholic beverage heavy drinkerAlcoholic steatohepatitisAlcoholsAnimal ExperimentsAnimalsAnti-Inflammatory AgentsApoptoticAppearanceAutopsyAwarenessBacterial TranslocationCell CountCell DeathCellsCessation of lifeChronicCirrhosisComplexDataDevelopmentDietDiseaseEquilibriumEtiologyEvolutionExcisionFailureFibrosisGene Expression ProfileGoalsHepaticHepatocyteHumanIL4 geneIn VitroIndividualInfiltrationInflammationInflammatoryInflammatory InfiltrateInflammatory ResponseInjuryInterleukin-13IntestinesKnowledgeKupffer CellsLiverLiver diseasesMacrophageMaintenanceMeasuresMinorityMusNatural regenerationNaturePatientsPatternPhenotypePlayPopulationPreventionProcessProductionPropertyRecoveryResearchResearch PersonnelResolutionRoleSeveritiesSignal TransductionSourceSpecimenTechniquesTimeTissuesTranscriptional ActivationWorkacute liver diseasealcohol exposurebinge drinkingcytokineexperimental studyfeedinggenetic signaturehepatocyte injuryin vivointrahepaticliver inflammationliver injuryliver transplantationmonocytemortalitymouse modelnovel therapeutic interventionperipheral bloodreceptorrepairedresponsesingle-cell RNA sequencingtissue injury
项目摘要
PROJECT TITLE: Role of macrophage evolution in hepatic adaptation to alcohol
PROJECT SUMMARY / ABSTRACT
Acute alcoholic hepatitis (AH) is a severe inflammatory liver disease triggered by binge drinking. The disease
has a 30-day mortality of approximately 20%. One of the most striking features of AH is that it affects only a
small minority of heavy drinkers suggesting that most individuals are protected from developing alcoholic liver
disease by as yet unknown mechanisms. We have recently shown that alcohol exposure in mice causes early
changes in liver macrophage (MΦ) populations with a loss of up to 50% of Kupffer cells and entry of infiltrating
macrophages. By 10 days, Kupffer cell numbers are restored but their gene expression patterns have become
more like anti-inflammatory M2 macrophages. By 35 days of alcohol exposure, the hepatic MΦ gene expression
pattern changes further with a decrease in some of the classic M2 markers and the development of a gene
expression pattern associated with a restorative MΦ phenotype. The macrophage population changes correlate
with changes in the sensitivity of the liver to a challenge with LPS. We hypothesize that the “lost” Kupffer cells
are rapidly replaced by “adaptive” macrophages leading to a state in which liver inflammation is minimal. This
adaptive macrophage formation requires Kupffer cell-derived apoptotic bodies and Th2 cytokines such as IL4
and IL13. The balance of pro-and anti-inflammatory MΦs and the nature of the hepatic adaptive MΦ populations
change over time so that with prolonged alcohol exposure, adaptation can be lost and liver inflammation can
occur. Better understanding of the nature of the adaptive macrophages and the factors that lead to their
formation, maintenance and loss would provide new approaches for the therapy of alcoholic liver disease. We
will explore this hypothesis with the following specific aims: Aim 1: To determine the origins, gene expression
patterns and functional properties of the mouse liver MΦ subtypes that appear after alcohol exposure.
We will use lineage tracing techniques and single cell RNA sequencing to define the origin and diversity of the
macrophage populations present. We will then isolate the adaptive macrophage populations to determine their
functional properties both in vivo and in vitro. Aim 2: To define the signals responsible for production and
maintenance of alcohol adaptive MΦ populations. We will examine the role of specific apoptotic body
receptors, the impact of different sources of apoptotic bodies, timing of apoptotic body formation within the liver,
and the role of hepatocyte derived factors in the formation of adaptive macrophage populations. Aim 3: To
identify macrophage/monocyte populations that contribute to alcohol adaptation in humans. These
experiments will leverage the mouse findings made in the first two aims to identify alcohol adaptive macrophage
populations in humans. This will be done by immunohistochemical analysis of macrophages in liver autopsy
specimens from non-drinkers and chronic alcohol drinkers without liver disease, and liver explants from patients
with alcoholic hepatitis. These will be compared to circulating blood monocytes in these patient groups and finally
will be compared with macrophages isolated from liver transplant explants of patients with alcoholic cirrhosis and
cirrhosis due to etiologies unrelated to alcohol. These studies will enhance our knowledge of how macrophage
phenotype changes protect the liver from alcohol, will identify the signals responsible for these changes and will
define which changes protect humans from alcoholic liver disease. The long-range goal of this research is to
develop macrophage directed therapies to modulate the course of alcoholic hepatitis and enhance anti-
inflammatory and tissue restorative effects in a wide range of inflammatory liver diseases.
项目名称:巨噬细胞演变在肝适应酒精中的作用
项目摘要 /摘要
急性酒精性肝炎(AH)是一种严重的炎症性肝病,是由暴饮暴食触发的。疾病
30天死亡率约为20%。 AH最引人注目的特征之一是它仅影响一个
少数少数饮酒者建议大多数人都受到保护,免受饮酒肝的发展
疾病尚未清楚的机制。我们最近表明,小鼠的酒精暴露会早期引起
肝巨噬细胞(Mφ)种群的变化,损失高达50%的库普弗细胞和渗透的进入
巨噬细胞。到10天,库普夫细胞数已经恢复,但它们的基因表达模式已成为
更像是抗炎的M2巨噬细胞。到35天的酒精暴露,肝Mφ基因表达
图案随着某些经典M2标记和基因的发展而进一步变化
与恢复性Mφ表型相关的表达模式。巨噬细胞的变化相关
随着肝脏对LPS挑战的敏感性的变化。我们假设“丢失”的库普弗细胞
迅速被“自适应”巨噬细胞替代,导致肝脏注射最少的状态。
自适应巨噬细胞形成需要库普弗细胞衍生的凋亡人体和Th2细胞因子(例如IL4)
和IL13。抗炎和抗炎的平衡以及肝自适应Mφ种群的性质
随着时间的流逝,随着时间的流逝,随着酒精的长时间暴露,适应可能会丢失,肝脏炎症可以
发生。更好地理解自适应巨噬细胞的性质以及导致其自适应的因素
形成,维持和损失将为酒精性肝病治疗提供新的方法。我们
将以以下特定目的探索这一假设:目标1:确定起源,基因表达
酒精暴露后出现的小鼠肝Mφ亚型的模式和功能特性。
我们将使用谱系跟踪技术和单细胞RNA测序来定义
存在巨噬细胞种群。然后,我们将分离自适应巨噬细胞以确定其
体内和体外的功能性能。目标2:定义负责生产的信号和
维持酒精自适应Mφ种群。我们将检查特定凋亡人体的作用
受体,凋亡人物不同来源的影响,肝脏内凋亡人体形成的时机,
肝细胞衍生因子在形成自适应巨噬细胞种群中的作用。目标3:到
确定巨噬细胞/单核细胞种群,导致人类的酒精适应。这些
实验将利用前两个目的中的小鼠发现来识别酒精自适应巨噬细胞
人类的人口。这将通过对肝尸检中巨噬细胞的免疫组织化学分析来完成
来自无肝病的非饮酒者和慢性酒精饮用者的标本,以及患者的肝外植体
与酒精性肝炎。这些将与这些患者组的循环血单核细胞进行比较,最后
将将酒精性肝硬化患者和
由于病因与酒精无关的肝硬化。这些研究将增强我们对巨噬细胞的了解
表型变化可保护肝脏免受酒精的影响,将确定负责这些变化的信号,并将
定义改变人类免受酒精性肝病的影响。这项研究的远程目标是
开发巨噬细胞定向疗法以调节酒精性肝炎的病程并增强抗
在多种炎症性肝病中的炎症和组织修复作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN A WEINMAN其他文献
STEVEN A WEINMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN A WEINMAN', 18)}}的其他基金
Kansas Center for Metabolism and Obesity REsearch (KC-MORE) - Administrative Core
堪萨斯代谢和肥胖研究中心 (KC-MORE) - 行政核心
- 批准号:
10598013 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Role of macrophage evolution in hepatic adaptation to alcohol.
巨噬细胞进化在肝脏适应酒精中的作用。
- 批准号:
10292924 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Role of macrophage evolution in hepatic adaptation to alcohol.
巨噬细胞进化在肝脏适应酒精中的作用。
- 批准号:
10045504 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Mechanisms of Liver Injury by Hepatitis C and Alcohol
丙型肝炎和酒精损伤肝的机制
- 批准号:
7928541 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Mechanisms of Liver Injury by Hepatitis C and Alcohol
丙型肝炎和酒精损伤肝的机制
- 批准号:
7907385 - 财政年份:2000
- 资助金额:
-- - 项目类别:
Role of alcohol adapted Kupffer cells in the progression and resolution of ALD
酒精适应库普弗细胞在 ALD 进展和消退中的作用
- 批准号:
10660796 - 财政年份:2000
- 资助金额:
-- - 项目类别:
Mechanisms of Liver Injury by Hepatitis C and Alcohol
丙型肝炎和酒精损伤肝的机制
- 批准号:
8812759 - 财政年份:2000
- 资助金额:
-- - 项目类别:
相似国自然基金
甲羟戊酸代谢途径影响双阴性调节性T细胞存活功能抑制非酒精性脂肪性肝炎的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
甲羟戊酸代谢途径影响双阴性调节性T细胞存活功能抑制非酒精性脂肪性肝炎的机制研究
- 批准号:82202021
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
靶向肝脏MST1的脂肪源性miRNA影响非酒精性脂肪性肝炎的机制研究
- 批准号:82160171
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
氧化磷酸化调控双阴T细胞免疫抑制功能影响非酒精性脂肪性肝炎发病的机制研究
- 批准号:81970503
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
特征肠道菌群影响非酒精性脂肪性肝炎的作用机制及其在临床诊断中的应用
- 批准号:81800517
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery after Liver Transplantation
肝移植后酒精使用障碍康复综合护理协调干预措施的开发和测试
- 批准号:
10723316 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The role of matrix-bound microvesicles in alcohol-related liver disease
基质结合微泡在酒精相关性肝病中的作用
- 批准号:
10582800 - 财政年份:2023
- 资助金额:
-- - 项目类别:
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis
一种创新的非噻唑烷二酮类泛 PPAR 激动剂,用于治疗酒精性肝炎
- 批准号:
10482468 - 财政年份:2022
- 资助金额:
-- - 项目类别: